Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Capital Expenditures: 2021-2025

Historic Capital Expenditures for MDxHealth (MDXH) over the last 4 years, with Sep 2025 value amounting to -$263,000.

  • MDxHealth's Capital Expenditures fell 25.24% to -$263,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year increase of 39.92%. This contributed to the annual value of $1.2 million for FY2024, which is 56.75% down from last year.
  • Per MDxHealth's latest filing, its Capital Expenditures stood at -$263,000 for Q3 2025, which was up 27.75% from -$364,000 recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Capital Expenditures peaked at $2.2 million during Q4 2024, and registered a low of -$925,000 during Q2 2022.
  • Over the past 2 years, MDxHealth's median Capital Expenditures value was -$263,000 (recorded in 2025), while the average stood at $174,200.
  • Per our database at Business Quant, MDxHealth's Capital Expenditures tumbled by 125.06% in 2022 and then grew by 25.24% in 2025.
  • Over the past 4 years, MDxHealth's Capital Expenditures (MRQ) stood at -$653,000 in 2021, then tumbled by 41.65% to -$925,000 in 2022, then skyrocketed by 336.11% to $2.2 million in 2024, then tumbled by 112.04% to -$263,000 in 2025.
  • Its last three reported values are -$263,000 in Q3 2025, -$364,000 for Q2 2025, and -$476,000 during Q1 2025.